title: Is there an optimal treatment sequencing strategy for metastatic castration-resistant prostate cancer?
authors: Jeanny B
authors: JB
authors: Aragon-Ching
mesh_terms: D059002:Androgen Receptor Antagonists / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000077143:Docetaxel; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D009362:Neoplasm Metastasis / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D011944:Receptors, Androgen / Q000235:genetics; D043823:Taxoids / Q000008:administration & dosage
chemical_list: D059002:Androgen Receptor Antagonists; D000970:Antineoplastic Agents; D011944:Receptors, Androgen; D043823:Taxoids; D000077143:Docetaxel; D008942:Mitoxantrone